Pharmacogenomics deals

Pharmacogenomics deals

PG provider Partner Focus Deal Value Year
deCode Vertex Autoimmune DCGN's Encode CRO subsidiary to gather and analyze PG data for VRTX compounds in clinical trials run by Encode, starting with ongoing Icelandic Phase Iia trial of VRTX's VX-148 to treat psoriasis. Companies have option to extend deal

Read the full 518 word article

How to gain access

Continue reading with a
two-week free trial.